These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36642429)

  • 21. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
    Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D
    Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
    Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
    Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of Atypical Hemolytic Uremic Syndrome.
    Yoshida Y; Kato H; Ikeda Y; Nangaku M
    J Atheroscler Thromb; 2019 Feb; 26(2):99-110. PubMed ID: 30393246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report.
    Torres EA; Chang Y; Desai S; Chang I; Zuckerman JE; Burwick R; Kalantar-Zadeh K; Hanna RM
    Case Rep Nephrol Dial; 2021; 11(1):95-102. PubMed ID: 33977097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report.
    Bruno V; Barth D; Jauhal A
    Can J Kidney Health Dis; 2023; 10():20543581231209009. PubMed ID: 37942411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Cavero T; Rabasco C; López A; Román E; Ávila A; Sevillano Á; Huerta A; Rojas-Rivera J; Fuentes C; Blasco M; Jarque A; García A; Mendizabal S; Gavela E; Macía M; Quintana LF; María Romera A; Borrego J; Arjona E; Espinosa M; Portolés J; Gracia-Iguacel C; González-Parra E; Aljama P; Morales E; Cao M; Rodríguez de Córdoba S; Praga M
    Nephrol Dial Transplant; 2017 Mar; 32(3):466-474. PubMed ID: 28339660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y; Miwa T; Ito D; Kim H; Sato S; Gullipalli D; Zhou L; Golla M; Song D; Dunaief JL; Palmer MB; Song WC
    Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA.
    Martis N; Jamme M; Bagnis-Isnard C; Pouteil-Noble C; Presne C; Vigneau C; Grangé S; Burtey S; Coindre JP; Wynckel A; Hamidou MA; Kanouni T; Azoulay E; Hié M; Chauveau D; Veyradier A; Rondeau E; Coppo P;
    Eur J Intern Med; 2021 Nov; 93():78-86. PubMed ID: 34175183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.
    Banjongjit A; Kittanamongkolchai W; Kanjanabuch T
    Nephron; 2023; 147(11):701-706. PubMed ID: 37611541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic Microangiopathies with Rheumatologic Involvement.
    Babar F; Cohen SD
    Rheum Dis Clin North Am; 2018 Nov; 44(4):635-649. PubMed ID: 30274628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature.
    Åkesson A; Zetterberg E; Klintman J
    Ther Apher Dial; 2017 Aug; 21(4):304-319. PubMed ID: 28508588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.
    El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP
    Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
    Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
    J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
    Fakhouri F; Frémeaux-Bacchi V
    Nat Rev Nephrol; 2021 Aug; 17(8):543-553. PubMed ID: 33953366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.